Executive Moves | Healthcare | BioTuesdays by Kilmer Lucas IR

Executive Moves

Salarius Pharma names Scott Jordan as CBO; Mark Rosenblum as EVP finance and interim CFO

Salarius Pharmaceuticals (NASDAQ:SLRX) has appointed Scott Jordan as chief business officer (CBO) and Mark Rosenblum as EVP finance and interim CFO. Mr. Jordan has been Salarius’ CFO since 2016. As CBO, he will lead...

September 13, 2019

Executive Moves

Adamas Pharma names Neil McFarlane as CEO

Neil McFarlane Adamas Pharmaceuticals (NASDAQ:ADMS) has appointed Neil McFarlane as CEO and a member of its board, effective Sept. 16. Gregory Went, Adamas’ founder, chairman and CEO, will transition to a strategic...

September 13, 2019

Executive Moves

Gritstone Oncology adds biotech veteran, Elaine Jones, to board

Elaine Jones Gritstone Oncology (NASDAQ:GRTS) appointed Elaine Jones as a director, replacing Peter Svennilson, founder of the Column Group and co-lead Series A investor in Gritstone. Dr. Jones was most recently VP...

September 12, 2019

Executive Moves

Spartan Bioscience boosts executive team

Closely-held Spartan Bioscience named Blaine Fitzgerald, former VP of finance for Shopify, as CFO. In addition, the company appointed Steve Edgett as EVP to lead its international business development and strategic...

September 5, 2019

Executive Moves

Zegbeh Jallah joins Roth heath care research team

Roth Capital Partners named Zegbeh Jallah as a director and research analyst covering biotechnology. Her research coverage is expected to include SMID cap biotech companies across the therapeutic space, with an initial...

August 27, 2019

Executive Moves

Axsome Therapeutics names David Marek as CCO

David Marek Axsome Therapeutics (NASDAQ:AXSM) has appointed David Marek as chief commercial officer, effective Aug. 31. Mr. Marek joins Axsome from Amgen (NASDAQ:AMGN), where he was most recently VP and general manager...

August 20, 2019

Executive Moves

Profound Medical names senior finance executive, Steve Forte, to board

Steve Forte Profound Medical (TSX:PRN; OTCQX:PRFMF) appointed seasoned cross-border finance leader, Steve Forte, as a director and member of the board’s audit committee. Most recently, Mr. Forte was CFO of Clementia...

August 15, 2019

Executive Moves

Strongbridge Biopharma reports key leadership appointments

Richard Kollender Strongbridge Biopharma (NASDAQ:SBBP) named Richard Kollender as COO, promoted Robert Lutz to CFO and appointed David Gill to its board, effective Sept. 3. “Continuing to assemble an experienced, multi...

August 14, 2019

Executive Moves

BriaCell Therapeutics names Richard Berman to board

BriaCell Therapeutics (TSXV:BCT; OTCQB:BCTXF) appointed Richard Berman to its board of directors. Mr. Berman has more than 35 years of experience in venture capital; senior management; and mergers and acquisitions. He...

August 13, 2019

Executive Moves

Kane Biotech strengthens animal health and quality assurance team

Kane Biotech (TSXV:KNE) added to its management team, hiring Lori Christofalos as the director of quality and compliance; Shabnam Bashiri as manager of quality control; and Michel Stebenne as VP of animal health. Ms...

August 12, 2019

Executive Moves

Hepion Pharma names renowned liver expert, Dr. Stephen Harrison, to its SAB

Stephen Harrison Dr. Stephen Harrison, a leading authority on liver diseases, has joined the scientific advisory board (SAB) of Hepion Pharmaceuticals (NASDAQ:HEPA). Dr. Harrison is a visiting professor of hepatology at...

August 7, 2019

Executive Moves

Soricimed taps industry veteran, Robert Bruce, as CEO

Closely-held Soricimed Biopharma appointed Robert Bruce as CEO, effective immediately, succeeding Paul Gunn, who continues as president. “Soricimed is taking an important step forward at this time and I am excited to...

July 17, 2019

Executive Moves

PharmaCyte appoints cellular expert, David Judd, to medical and SAB

David Judd PharmaCyte Biotech (OTCQB: PMCB) appointed David Judd to its medical and scientific advisory board. Mr. Judd has had over 30 years of experience in the research and development of cell culture materials and...

July 15, 2019

Executive Moves

Rahul Sarugaser joins Raymond James’ life sciences research team

Rahul Sarugaser Rahul Sarugaser has joined Raymond James’ Canadian equity research team as managing director, equity analyst, healthcare, biotechnology & cannabis. Most recently, Mr. Sarugaser was an equities...

July 12, 2019

Executive Moves

John Baumgartner named Lake Street’s head of capital markets

Lake Street Capital Markets has named John Baumgartner as its head of capital markets, responsible for overseeing marketing, pricing, and distribution of its capital raising activities. Mr. Baumgartner began his career...

July 12, 2019

Executive Moves

IDEAYA Biosciences makes three appointments to management team

IDEAYA Biosciences (NASDAQ:IDYA) promoted Paul Stone to CFO, Andres Briseno to VP finance, and Mick O’Quigley to VP development operations. Continuing his role as IDEAYA’s principal financial and accounting...

July 9, 2019

Executive Moves

ORIC Pharma names Lori Friedman as CSO

Closely-held ORIC Pharmaceuticals appointed Lori Friedman as CSO, responsible for leading ORIC’s research and preclinical development efforts.

July 9, 2019

Executive Moves

Zenabis’ expansion welcomed by Stellarton residents

Zenabis Global’s (TSX:ZENA) expansion in Stellarton, Nova Scotia, is good news for local residents, as the company is looking to fill several positions at that particular facility this summer.

July 4, 2019

Executive Moves

Alternate Health names Dr. Robert Blaine as president, CMO and director

Alternate Health (CSE:AHG; OTCQB:AHGIF) appointed Dr. Robert Blaine as president, CMO and a director, effective immediately.

July 3, 2019

Executive Moves

Canopy Growth announces senior management changes

Bruce Linton is stepping down as co-CEO and a director of Canopy Growth (TSX:WEED; NYSE: CGC) and Mark Zekulin, co-CEO, has agreed to become sole CEO.

July 3, 2019

Executive Moves

BioSig names Samuel Navarro to board

BioSig Technologies (NASDAQ:BSGM) appointed Samuel Navarro as an independent director.

June 25, 2019

Executive Moves

Arcus Biosciences names Eric Hoefer as chief commercial officer

Arcus Biosciences (NYSE:RCUS) appointed Eric Hoefer as its chief commercial officer to oversee the company’s global commercial strategy and operations.

June 24, 2019

Salarius Pharma names Scott Jordan as CBO; Mark Rosenblum as EVP finance and interim CFO

Adamas Pharma names Neil McFarlane as CEO

Gritstone Oncology adds biotech veteran, Elaine Jones, to board

Spartan Bioscience boosts executive team

Zegbeh Jallah joins Roth heath care research team

Axsome Therapeutics names David Marek as CCO

Profound Medical names senior finance executive, Steve Forte, to board

Strongbridge Biopharma reports key leadership appointments

BriaCell Therapeutics names Richard Berman to board

Kane Biotech strengthens animal health and quality assurance team

Hepion Pharma names renowned liver expert, Dr. Stephen Harrison, to its SAB

Soricimed taps industry veteran, Robert Bruce, as CEO

PharmaCyte appoints cellular expert, David Judd, to medical and SAB

Rahul Sarugaser joins Raymond James’ life sciences research team

John Baumgartner named Lake Street’s head of capital markets

IDEAYA Biosciences makes three appointments to management team

ORIC Pharma names Lori Friedman as CSO

Zenabis’ expansion welcomed by Stellarton residents

Alternate Health names Dr. Robert Blaine as president, CMO and director

Canopy Growth announces senior management changes

BioSig names Samuel Navarro to board

Arcus Biosciences names Eric Hoefer as chief commercial officer

General

More